376
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Preventing atrial fibrillation in COVID-19: exploring the role of interleukin-6 receptor antagonists

, & ORCID Icon
Pages 713-714 | Received 02 Sep 2023, Accepted 26 Sep 2023, Published online: 04 Oct 2023
 
This article responds to:
In response to: preventing atrial fibrillation in COVID-19: exploring the role of interleukin-6 receptor antagonists

Conflict of interest

All authors declare that they have no potential conflicts of interest that might be relevant to the contents of this article.

Declaration of interest

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Additional information

Funding

This paper was not funded. No external funding was used in the preparation of this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.